For moderately preterm infants, extending the caffeine treatment often used for apnea of prematurity for 28 days after discharge did not help them get home from the hospital sooner, the MoCHA ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended ...

The Trump administration told researchers it was “releasing” them from their roles. It puts the future of the assessment, ...

Hospital closures, specifically in rural and underserved areas, have become a growing concern among many healthcare leaders, as they drive up costs and patient demand for other area facilities while ...

The National Academy of Sciences has received a $20 million donation from the family of Philip Needleman, an NAS and NAM ...

Heavy actinides—elements at the bottom of the periodic table, after plutonium—are radioactive, rare and chemically complex, ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Cancer research in the U.S. doesn't rely on a single institution or funding stream − it's a complex ecosystem made up of ...

Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...